Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Zamboni

Showing results (31-40 of 180) with videos related to

Pageof 18
Sort By:
Journal of Clinical Pharmacology|November 9, 2023
Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer AgentsWilliam C Zamboni, Rosane Charlab, Gilbert J Burckart, et al.
Pharmaceutics|January 22, 2021
Complex Factors and Challenges that Affect the Pharmacology, Safety and Efficacy of Nanocarrier Drug Delivery SystemsJoseph A Piscatelli, Jisun Ban, Andrew T Lucas, et al.
Giornale Di Batteriologia, Virologia Ed Immunologia|July 1, 1984
Adherence of Staphylococcus strains to human urinary and buccal epithelial cellsM Carbone, M T Fera, G Stassi, et al.
Antibodies (Basel, Switzerland)|August 27, 2021
Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist's PerspectiveAndrew T Lucas, Amber Moody, Allison N Schorzman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 27, 2002
Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasmaRobert A Parise, Ramesh K Ramanathan, William C Zamboni, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2018
Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated AgentsAllison N Schorzman, Andrew T Lucas, John R Kagel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
A review of study designs and outcomes of phase I clinical studies of nanoparticle agents compared with small-molecule anticancer agentsWhitney P Caron, Katherine P Morgan, Beth A Zamboni, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 31, 2019
Patterns and characteristics associated with surface contamination of hazardous drugs in hospital pharmaciesStephanie A Salch, William C Zamboni, Beth A Zamboni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Disposition of irinotecan and SN-38 following oral and intravenous irinotecan dosing in miceC F Stewart, W C Zamboni, W R Crom, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 17, 2014
From immunotoxicity to nanotherapy: the effects of nanomaterials on the immune systemMatthew J Smith, Jared M Brown, William C Zamboni, et al.
Pageof 18

Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
Journal of Clinical Pharmacology|November 9, 2023
Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer AgentsWilliam C Zamboni, Rosane Charlab, Gilbert J Burckart, et al.
Pharmaceutics|January 22, 2021
Complex Factors and Challenges that Affect the Pharmacology, Safety and Efficacy of Nanocarrier Drug Delivery SystemsJoseph A Piscatelli, Jisun Ban, Andrew T Lucas, et al.
Giornale Di Batteriologia, Virologia Ed Immunologia|July 1, 1984
Adherence of Staphylococcus strains to human urinary and buccal epithelial cellsM Carbone, M T Fera, G Stassi, et al.
Antibodies (Basel, Switzerland)|August 27, 2021
Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist's PerspectiveAndrew T Lucas, Amber Moody, Allison N Schorzman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 27, 2002
Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasmaRobert A Parise, Ramesh K Ramanathan, William C Zamboni, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2018
Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated AgentsAllison N Schorzman, Andrew T Lucas, John R Kagel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
A review of study designs and outcomes of phase I clinical studies of nanoparticle agents compared with small-molecule anticancer agentsWhitney P Caron, Katherine P Morgan, Beth A Zamboni, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 31, 2019
Patterns and characteristics associated with surface contamination of hazardous drugs in hospital pharmaciesStephanie A Salch, William C Zamboni, Beth A Zamboni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Disposition of irinotecan and SN-38 following oral and intravenous irinotecan dosing in miceC F Stewart, W C Zamboni, W R Crom, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 17, 2014
From immunotoxicity to nanotherapy: the effects of nanomaterials on the immune systemMatthew J Smith, Jared M Brown, William C Zamboni, et al.
Pageof 18